Sales decline 13.63% to Rs 83.49 crore
Net loss of Tatva Chintan Pharma Chem reported to Rs 0.66 crore in the quarter ended September 2024 as against net profit of Rs 7.78 crore during the previous quarter ended September 2023. Sales declined 13.63% to Rs 83.49 crore in the quarter ended September 2024 as against Rs 96.67 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales83.4996.67 -14 OPM %6.6820.94 -PBDT5.7917.99 -68 PBT-1.0211.21 PL NP-0.667.78 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "result, q1, q2, q3, q4")
 "Robert Habeck")
 "mutual fund investors")
 "Bharat Petroleum")
 "MUDRA loan.")
